Cannabinoids Ease Motor Symptoms in Mouse Model of Parkinson’s, Early Results Show

Cannabinoids Ease Motor Symptoms in Mouse Model of Parkinson’s, Early Results Show
Cannabinoid-based formulations in development at GB Sciences were able to ease behavioral symptoms linked to the loss of dopamine producing-nerve cells — a hallmark of Parkinson’s — in a mouse model of the disease, the company said. GB Sciences will use these early results to support an Investigational New Drug Application it plans to file with the U.S. Food and Drug ... read more
Source: Parkinson’s News TodayPublished on 2020-01-07By Patricia Inacio, PhD